Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03966534
Other study ID # 0177-18-SZMC
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2018
Est. completion date February 28, 2019

Study information

Verified date September 2018
Source Shaare Zedek Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomized partially controlled study to examine the effect of blood diversion into a heparin lithium tube on the incidence of blood culture contamination.


Recruitment information / eligibility

Status Completed
Enrollment 970
Est. completion date February 28, 2019
Est. primary completion date February 28, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age > 18

- Presence in Emergency Room during extended office hours (0800-2000 on weekdays(

- Clinical requirement for Blood culture and biochemistry tests from venepuncture

Exclusion Criteria:

- None

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Blood diversion
Diversion of initial blood obtained at venipuncture to biochemistry tube in order to try and reduce incidence of blood culture contamination

Locations

Country Name City State
Israel Shaare Zedek Medical Center Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Shaare Zedek Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood culture contamination Growth of bacteria defined as blood culture contaminants (for example coagulase negative staphylococci in one bottle only). up to 7 days from obtaining blood culture
Secondary Patient length of stay Length of stay from arrival at Emergency room until discharge in hours up to 3 months from arrival
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05576233 - • Comparison of Blood Culture Contamination Rates N/A
Completed NCT04573894 - Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations